Ifp Advisors, Inc Gamida Cell Ltd. Call Options Transaction History
Ifp Advisors, Inc
- $2.42 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding GMDA
# of Institutions
1Shares Held
2.2KCall Options Held
0Put Options Held
0About Gamida Cell Ltd.
- Ticker GMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,319,600
- Market Cap $2.29M
- Description
- Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...